胶质瘤中的caspase-3通过参与周围血管生成和肿瘤细胞再增殖提示不良预后
该研究利用胶质瘤组织芯片和CGGA mRNA芯片数据,发现cleaved caspase-3高表达与胶质瘤患者生存期差相关,且与微血管密度高相关;体外共培养模型显示照射后胶质瘤细胞中的caspase-3通过调控COX-2信号介导促血管生成和促再增殖效应。
要点
- cleaved caspase-3高表达与胶质瘤患者生存期差及微血管密度高相关。
- CASP3高表达见于KPS评分低、WHO分级高、恶性组织学亚型及IDH野生型患者。
- 体外共培养模型显示照射后胶质瘤细胞的caspase-3经COX-2信号介导促血管生成和促再增殖效应。
核心结论
- 该研究创新性地发现caspase-3在胶质瘤中具有不良预后作用。
- caspase-3/COX-2信号的促血管生成和促再增殖效应可能解释其不良预后作用。
研究设计与样本
- 利用胶质瘤组织芯片探索cleaved caspase-3的预后作用及其与血管生成的关联。
- 分析CGGA的mRNA芯片数据,研究CASP3表达的预后作用及其与胶质瘤血管生成和增殖标志物的相关性。
- 采用体外细胞共培养模型,由照射后的U87细胞与未照射的Fluc标记HUVEC(HUVEC-Fluc)或U87(U87-Fluc)细胞组成。
- 使用过表达的显性负性caspase-3抑制正常caspase-3活性。
主要发现
- cleaved caspase-3高表达水平与胶质瘤患者较差的生存结局相关。
- cleaved caspase-3高表达患者中观察到更高的微血管密度。
- CGGA芯片数据显示,CASP3表达较高见于Karnofsky功能评分较低、WHO分级较高、恶性组织学亚型及IDH野生型的胶质瘤患者。
- CASP3表达较高提示胶质瘤患者生存率较差;CASP3高表达且IDH突变阴性的患者生存率最差。
- CASP3与肿瘤血管生成和增殖标志物呈正相关。
关键数值与推荐
- cleaved caspase-3高表达与胶质瘤患者较差的生存结局相关。
- cleaved caspase-3高表达患者中微血管密度更高。
- CASP3表达较高见于Karnofsky功能评分较低、WHO分级较高、恶性组织学亚型及IDH野生型的胶质瘤患者。
- CASP3高表达且IDH突变阴性的胶质瘤患者生存率最差。
- cleaved caspase-3和COX-2均高表达的胶质瘤患者生存结局最差。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Effective biomarkers for estimating glioma prognosis are deficient. Canonically, caspase-3 acts as an "apoptosis executioner". However, its prognostic role in glioma and mechanistic effects on prognosis remain unclear. METHODS: With glioma tissue microarrays, the prognostic roles of cleaved caspase-3 and its association with angiogenesis were explored. Next, by analyzing the mRNA microarray data from the CGGA, the prognostic role of CASP3 expression and correlations between CASP3 and markers of glioma angiogenesis and proliferation were investigated. To biologically interpret the prognostic role of caspase-3 in glioma, the influence of caspase-3 on surrounding angiogenesis and glioma cell repopulation was investigated with an in vitro cell co-culture model, which comprises irradiated U87 cells and un-irradiated firefly luciferase (Fluc)-labeled HUVEC (HUVEC-Fluc) or U87 (U87-Fluc) cells. The over-expressed dominant-negative caspase-3 was used to suppress normal caspase-3 activity. RESULTS: High levels of cleaved caspase-3 expression were associated with poor survival outcomes in glioma patients. Higher microvessel density was observed in patients with high levels of cleaved caspase-3 expression. By mining the microarray data in CGGA, it was revealed that higher CASP3 expression was found in glioma patients with lower Karnofsky Performance score, higher WHO grade, malignant histological subtype, wild-type IDH. Higher CASP3 expression indicated a worse survival rate in glioma patients. Patients with high CASP3 expression and negative IDH mutation showed the worst survival rate. Positive correlations were found between CASP3 and markers of tumor angiogenesis and proliferation. Subsequent data based on an in vitro cell co-culture model revealed that caspase-3 in irradiated glioma cells mediated pro-angiogenic and repopulation-promoting effects via regulating COX-2 signaling. With glioma tissue microarrays, high levels of COX-2 expression showed inferior survival outcomes in glioma patients. Glioma patients with high levels of cleaved caspase-3 and COX-2 expression showed the worst survival outcomes. CONCLUSION: This study innovatively identified an unfavorable prognostic role of caspase-3 in glioma. The pro-angiogenic and repopulation-prompting effects of caspase-3/COX-2 signaling may explain its unfavorable prognostic role and offer novel insights into therapy sensitization and curative effect prediction of glioma.
引用
- Feng X, Zhu F, Dai L, et al. Caspase-3 in glioma indicates an unfavorable prognosis by involving surrounding angiogenesis and tumor cell repopulation. J Neurooncol. 2023. PMID: 37195411. doi:10.1007/s11060-023-04339-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。